跳至主要内容
临床试验/NCT07364058
NCT07364058尚未招募不适用

Assessment of Platelet-derived GARP in Atherosclerotic Disease

Université Catholique de Louvain1 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2026年2月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
尚未招募
入组人数
200
试验地点
1
主要终点
GARP Expression in Platelets

研究概览

简要总结

The leading cause of death is cardiovascular diseases in occidental countries. Of those, atherosclerosis is the major contributor to this burden being notably responsible for strokes and myocardial infarctions. The genesis of atherosclerosis is linked to both lipid accumulation and inflammation in the vascular wall of major arteries. One of the major pathways of inflammation is the TGF-beta axis which is at least partially regulated by the GARP protein. It has been investigated mostly in cancer biology but data in cardiovascular disease is lacking. Thus, the investigators aim to characterize the contribution of this protein by investigating its expression in tissue from patients with atherosclerosis, the carotid or femoral plaque representing a good source of residual material adequate for research purpose. The main cells expressing the GARP protein are the platelets and the T regulating cells which will be the main focus.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Older than 18 years
  • Able to give informed consent
  • Undergoing carotid or femoral endarterectomy

排除标准

  • Younger than 18 years
  • Unable to give informed consent

研究组 & 干预措施

Endarterectomy population

This group includes patients with significant atherosclerotic burden justifying a surgical intervention of carotid or femoral endarterectomy.

干预措施: Tissue sample and data collection (Other)

结局指标

主要结局

GARP Expression in Platelets

时间窗: Throughout the entire study, approximately during 3 years

The number of cells/area expressing the GARP protein will be assessed

次要结局

  • GARP Expression T Regulating Cells(Throughout the entire study, approximately during 3 years)
  • GARP Expression General(Throughout the entire study, approximately during 3 years)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验